Laurence Morand‐Joubert

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

Jean‐Luc Meynard, Muriel Vray, Laurence Morand‐Joubert et al. · AIDS · 2002 · 244 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected Persons

Jean‐Jacques Lefrère, Françoise Roudot‐Thoraval, Laurence Morand‐Joubert et al. · The Journal of Infectious Diseases · 1999 · 147 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies

Florent Malard, Béatrice Gaugler, Joël Gozlan et al. · Blood Cancer Journal · 2021 · 144 citations · Full text

Veterinary Medicine, Hematology, Immunology +17

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study

Lawrence Serfaty, Olivier Chazouillères, Armelle Poujol‐Robert et al. · Hepatology · 1997 · 124 citations · Full text

Medicine, Infectious Diseases, Genetic Epidemiology +16

Detection of Minority Populations of HIV-1 Expressing the K103N Resistance Mutation in Patients Failing Nevirapine

Denise Lecossier, Nancy S. Shulman, Laurence Morand‐Joubert et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 105 citations

Life Sciences, Genetics, Infectious Diseases +17